Who invested in Insight Genetics

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow Insight Genetics and see its new rounds in your feed. Start following

Funding summaryUpdated 15 Nov 2026

$4.5Mraised across 2 rounds since 2013, from 2 sources

$1.5MGrant$3.0MDebt

Latest round: Debt, $3.0MNov 2015
Step-upi: 2×
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142015

$1.5MGrant$3.0MDebt

First round: Grant, $1.5M
Biggest round: $3.0M
Between rounds: 2.2 years

The rounds

Nov 2015
Debt$3.0M
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Oct 2015
Aug 2013
Grant$1.5M
No investor was named in the report.
Reported by nashvillepost.com

Funding filed with regulators

Insight Genetics filed one raise, $3.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

Oct 2015$3.0M1 investordebt, optionsof $5.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 5 on the team.

Christopher T. CallaghanPresident and Chief Operating Officeri
Eric B. DahlhauserChief Executive Officer and Chairman of the Board of Directorsi
David A. HoutVice President of Research and Developmenti
Rob A. SeitzChief Technology Officeri
Stephan A. MorrisChief Scientific Officeri